Neon Therapeutics Q3 EPS $(0.68) Down From $(0.67) YoY

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.68) per share. This is a 1.49 percent decrease over losses of $(0.67) per share from the same period last year.

Benzinga · 11/12/2019 13:01

Neon Therapeutics (NASDAQ:NTGN) reported quarterly losses of $(0.68) per share. This is a 1.49 percent decrease over losses of $(0.67) per share from the same period last year.